TORNTPHARMNSETorrent Pharmaceuticals Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 11 May · 21:16 IST

Torrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.4%1-day move
₹4518.00
prior close
₹4509.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.6-1.7-1.9-1.5-4.4-2.5-3.0-2.5-1.5-1.0-3.3+1.3+9.5
Up moveDown movePending
AI summary

Torrent Pharmaceuticals has published a newspaper notice regarding a Company Petition hearing before the National Company Law Tribunal (NCLT) Bench at Ahmedabad. The petition relates to the Scheme of Arrangement for amalgamation of J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) into Torrent Pharmaceuticals. Following an order dated 7th May 2026, the NCLT hearing is scheduled for Thursday, 11th June 2026. Any person wishing to support or oppose the petition must submit their representation at least two days before the hearing date. This is a regulatory requirement under Regulation 30 of SEBI (LODR) Regulations, 2015, disclosing the progress of this proposed merger to the exchanges and public.

Likely market impact

This indicates the JB Pharma-Torrent Pharma amalgamation is advancing through legal channels toward NCLT sanction. If approved, this would be a significant consolidation in the Indian pharmaceutical sector, potentially expanding Torrent Pharma's product portfolio and market presence. Shareholders of both companies should monitor the NCLT outcome on 11th June 2026.